All sponsors

Teva Branded Pharmaceutical Products R&D LLC $TEVA

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-32
RECRUITING1
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO20%

Delay Index: of 5 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +3.9 months). See all sponsors →

Open Teva Branded Pharmaceutical Products R&D LLC on the live radar map → 📅 $TEVA readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
TEV-48574 Dose Regimen A
NCT05668013
P2Active, not recruitingCrohn Disease; Colitis, Ulcerative2472026-01-05 (+12 mo)
TEV-53408
NCT06807463
P2Active, not recruitingCeliac Disease502026-10-02 (+2 mo)
TEV-56248
NCT06052267
P3Active, not recruitingAsthma27692026-12-31 (+5 mo)
TOPAS-MSA
NCT06568237
P2Active, not recruitingMultiple System Atrophy3492027-09-15 (+4 mo)
TEV-56286
NCT07197866
P2RecruitingMultiple System Atrophy2002029-05-03
TEV-53408 Dose A
NCT07920211
P2/3Not yet recruitingVitiligo10202030-09-12